The N-terminal domain of the Epa1p adhesin from Candida glabrata (N-Epa1p) is a calciumdependent lectin, which confers the opportunistic yeast the ability to adhere to human epithelial cells. This lectin domain is able to interact with galactosides and, more precisely, with glycan molecules containing the Gal-1,3-GalNAc disaccharide, also known as the T-antigen. Based on the crystallographic structure of the N-Epa1p domain and the role of the variable loop CBL2 in glycan binding, saturation mutagenesis on some residues of the CBL2 loop was used to increase the binding affinity of N-Epa1p for fibronectin, which was selected as a model of a human glycoprotein. Two adhesin mutants, E227A and Y228W, with improved binding features were obtained. More importantly, a glycan array screening revealed that single point mutations in the CBL2 could produce significant changes in the carbohydrate specificity of the protein. In particular, lectin molecules were generated with a high affinity for sulfated glycans, which may find an application as molecular probes for the identification of 6-sulfogalactose containing glycans and glycoconjugates.
Introduction
The yeast Candida glabrata is a commensal member of the human microbiome. It is especially localized in the mucosae of different organs, where it doesn't represent a threat for individuals in healthy conditions. However, it may become a problem in patients whose immune system has been compromised, including HIV seropositive patients or organ transplant acceptors (Fidel et al., 1999; Pelroth et al., 2007) . In combination with the more virulent C. albicans, it can cause localized infections, such as oropharyngeal candidiasis, esophagitis, vulvovaginitis and urinary tract infections, or in the worst cases even systemic candidiasis. C. glabrata and other non-albicans Candida species are considered nowadays as emerging opportunistic organisms, as they represent the etiological agents of an increasing number of fungal infections. This depends especially on the resistance of these yeasts to several antimicrobial agents (Miceli et al., 2011) .
Adherence of C. glabrata to human epithelial cells mainly relies on Epa (epithelial adhesins)
proteins, especially on Epa1p, Epa6p and Epa7p (Cormack et al., 1999; Frieman et al., 2002; Castano et al., 2005) , which are endowed with a calcium-dependent and lactose-sensitive lectin functionality (Cormack et al., 1999) . Epa1p and Epa7p can also mediate adherence to endothelial cells (Zupancic et al., 2008) , while Epa1 can adhere to macrophages and peripheral blood mononuclear cells (Kuhn and Vyas, 2012) . The Epa proteins are glycosylphosphatidylinositolanchored cell wall proteins (GPI-CWP), characterized by a well-defined modular structure (Frieman et al., 2002) . The N-terminal domain confers the protein the ability to adhere to the host cells, while the central serine/threonine-rich region has the structural role of extending the ''sticky'' domain outwards of the cell wall. The C-terminus is modified with a GPI function and keeps the protein attached to the cell wall.
The structure and function of Epa proteins has been thoroughly studied not only at the cellular level, but also at the molecular level. An in-depth binding characterization of the N-terminal domain of Epa proteins (N-Epa1p, N-Epa6p, N-Epa7p) has been performed by means of glycan array analysis (Zupancic et al., 2008; Maestre-Reyna et al., 2012) . N-Epa1p can recognize galactose-containing glycans with a specificity for -1,3-and -1,4-linked galactose moieties, but it shows preference for glycan structures containing the core 1 structure of mucin-type O-glycans, also known as the Tantigen (Gal-1,3-GalNAc). The 3D structure of N-Epa1p has been solved by X-ray crystallography (Ielasi et al., 2012) . The adhesin is able to recognize carbohydrate ligands with micromolar affinity via 4 a PA14 domain (Rigden et al., 2004) . This domain has a PA14-like -sandwich topology and contains a calcium-dependent carbohydrate binding pocket. The CBL2 loop, a variable loop whose amino acid side chains regulate the specificity and the promiscuity of the binding pocket (Ielasi et al., 2012; Maestre-Reyna et al., 2012) , is important for the interaction with disaccharides and larger glycan determinants.
Fibronectin (FN) is a large glycoprotein assembled from two 250 kDa subunits and characterized by three different types of sequence repeats (Buck and Horwitz, 1987; Pankov and Yamada, 2002) . It contains different binding sites for other molecules of the extracellular matrix (ECM), including proteins like fibrin, collagen and integrins, as well as glycosaminoglycans such as heparin. Several forms of this protein (at least 20) are present in the human body. They are all encoded by the same gene, and based on their solubility, they can be classified either as plasma FN or as cellular FN. The former is a soluble form of the glycoprotein; it is present in blood plasma and involved in wound healing and blood clotting by interacting with platelets and fibrin (Lenselink, 2013) .
Fibronectin glycosylation mainly consists of complex-type N-glycans with non-reducing terminal lactosamine moieties. The presence of additional sialic acid or fucose residues is typical for respectively the soluble plasmatic and cellular form of fibronectin (Takasaki et al., 1980; Wang et al., 1990; Tajiri et al., 2005) . Mucin-type O-glycosylation was also found on plasma fibronectin, particularly in the forms of T-antigen and sialyl-T-antigen (Tajiri et al., 2005) .
Several strategies have been used so far to engineer carbohydrate-binding properties of lectins, including random mutagenesis (Yabe et al., 2006) , site-directed mutagenesis (Salomonsson et al., 2010) or the combination of these methods ). An additional semi-random technique is saturation mutagenesis, which allows generating all possible mutations for a specific site and has been successfully used to change the carbohydrate specificity of structurally characterized proteins (Imamura et al., 2011; Hu et al., 2013) .
In this work, we use saturation mutagenesis in combination with an ELISA-based detection method to engineer the carbohydrate binding properties of N-Epa1p. First, we found that fibronectin, purified from human plasma, is recognized by N-Epa1p with submicromolar affinity and that its binding with the adhesin domain is lactose sensitive. Next, fibronectin was selected as a model ligand for N-Epa1p, to assess the suitability of a saturation mutagenesis method for adhesin engineering.
Specifically, we aimed to increase the N-Epa1p affinity for glycosylated fibronectin. Two positions in by guest on July 21, 2014 http://glycob.oxfordjournals.org/ Downloaded from the N-Epa1p variable loop CBL2, namely E227 and Y228 (Figure 2A ), were selected as targets for mutagenesis, since they are critical for the interaction with large glycan structures (Maestre-Reyna et al., 2012) . The binding properties of the selected hits from the mutant screening were characterized quantitatively by surface plasmon resonance, and qualitatively by glycan array screening. It was found that specific mutations in the CBL2 loop not only increased the affinity for the glycoprotein but also modified the carbohydrate specificity, specifically towards the recognition of sulfated glycan moieties.
Results

Binding of wild type N-Epa1p to fibronectin
Surface Plasmon Resonance (SPR) was used to measure the affinity of N-Epa1p for fibronectin, that was immobilized onto the surface of a sensor chip ( Figure 1A ). The equilibrium dissociation constant (K D ) value was estimated at 911 nM. In order to verify that the observed interaction was specifically mediated by galactose-containing glycans attached to fibronectin, binding inhibition experiments were performed by applying solutions with a constant N-Epa1p concentration and increasing concentrations of lactose or glucose to the sensor chips ( Figure 1B ). The binding of N-Epa1p to fibronectin could be blocked by lactose in a concentration-dependent manner, but was not affected by the presence of glucose.
Optimization of binding detection
A detection system based on an ELLA setup was chosen to detect binding of mutants of the Epa1p lectin domain to fibronectin. This system is based on the spectrophotometric identification of the lectin -anti-His antibody -anti-mouse-alkaline phophatase (AP) antibody complexes bound to the immobilized glycoprotein ligand. Prior to the mutant screenings, the conditions for the assays had to be optimized, especially in terms of the amount of glycoprotein ligand immobilized in the microtiter plate. Other elements also had to be checked, such as the absence of any non-specific binding event taking place in parallel to the N-Epa1p -fibronectin interaction and the reproducibility of the detection.
A preliminary assay was performed by using a 96-well plate with different amounts of immobilized fibronectin. Glycoprotein solutions of 10, 5, 2.5, 1 and 0 g/ml and 2% w/v BSA were used for ligand coating and blocking, respectively. The plate was incubated with cell lysate samples, coming from a wild-type-only culture plate, and lysis buffer as a negative control. The increase in A second preliminary assay was conducted to determine the variability of the detection method. Wells coated with the same amount of fibronectin were incubated with cell lysate samples coming from a wild-type culture plate. Binding was detected in the same way as described before, and the slopes were calculated over 1 h of absorbance data. The coefficient of variability (CV) of 38 slope values from the same number of wells, was calculated to be 22.3%. This variability can be considered as reasonably low, considering that crude cell lysate (from different bacterial colonies) and unpurified N-Epa1p samples were used, and slight differences among protein expression yields may exist.
Detection of mutants with improved ligand binding affinity
The optimized ELLA method was used to identify N-Epa1p mutants with higher binding affinities for fibronectin. Libraries of variants with E227 and Y228 single-point mutations were screened ( Figure   2B ). From the E227 library, only 6 clones satisfied our selection criterion (Avg+2xSD), while other clones showed similar or lower binding compared to the wild-type N-Epa1p. Sequencing of the hits revealed three times the mutant E227G and twice the mutant E227A. The top hit turned out to be a wild-type construct, which must be a false-positive result since no mutations could be found in the complete sequenced region (between the T7 promoter and the T7 terminator of the plasmid). The Y228 library generated more than double the amount of hits, and among the 14 clones satisfying the selection criteria, the 8 highest-ranking were subjected to further investigation.
Sequencing detected 7 times the Y228W mutant (present in the 5 highest positions in the ranking) and once the Y228A mutant. Generally, 60% of the constructs showed activity similar to or lower than the wild-type construct.
Binding characterization of the N-Epa1p mutants
Interactions of the identified N-Epa1p mutants with fibronectin were further investigated by means of SPR. This characterization was essential to rule out the possibility that the hits, obtained from the initial ELLA screening, are simply related to different protein yields from the bacterial expression system. Solutions containing different concentrations of the mutant proteins were injected onto sensor chips functionalized with the glycoprotein ligand. Response values at equilibrium were extracted from sensorgrams ( Figure 1C ) and used to calculate equilibrium dissociation constants. Analysis of NEpa1p variants revealed a substantially unchanged affinity for the Y228A hit (1.15 M), a decreased affinity for the E227G hit (1.72 M) and an increased affinity for the E227A and Y228W hits (317 nM and 545 nM, respectively).
Glycan array screening of the N-Epa1p mutants
We subjected the four hit mutants to a semi-quantitative glycan array screening in order to determine if a single-point mutation can produce significant changes in carbohydrate specificities of N-Epa1p.
We found indeed some major changes in ligand specificity for some of the mutants, tested at 200 g/ml on the glycan arrays ( Figure S2 and Table S1 ). Particularly, the E227A mutant could bind strongly all lactose and lactosamine structures with a sulfated hydroxyl on galactose C6 ([6-SO 3 -]Gal-1,4-Glc/GlcNAc, glycan n. 42-45, 297), and among these, preference was found for a second sulfation on glucose/glucosamine 6-OH (glycan n. 45 and 297). While the mutation retained the affinity for glycans containing Gal-1,3-GalNAc and Gal-1,3-GlcNAc moieties, it changed in regards to the recognition of the sulfated structures, which became the highest-affinity carbohydrate ligands among all the carbohydrates present in the glycan array. A completely new ligand has also been found, i.e. a lactosamine with a phosphate group on the galactose 6-OH -]Gal-1,4-GlcNAc, glycan n. 518), and it binds to N-Epa1 with a higher specificity than lactosamine.
The only major variation in the glycan array profile of Y228W, compared to the wild type adhesin, is the decreased binding to glycans containing a -1,4-linked galactose (glycan n. and to complex N-glycans and related branches (glycan n. 351-575). On the other hand, a change in specificity similar to that observed for E227A, was observed for the E227G variant. Although the interaction with glycans is significantly diminished, this N-Epa1p variant is still able to recognize lactose and lactosamine with a sulfate group on both C6 hydroxyl groups or with a single sulfate on the glucose ring (glycan n. 45, 155, 156), but not the analogues ones with only one sulfate on the galactopyranose ring. Next best binders include structures with a -1,3-linked galactose, and the mutant is not able anymore to recognize highly-branched glycan structures. This results in a N-Epa1p variant characterized by lower affinity for carbohydrates, but also with a very narrow specificity. The variant Y228A shows also increased binding to the disaccharides containing two sulfated hydroxyls on the C6, but it recognizes mostly Gal-1,3-containing substructures and, unlike the wild type, preferentially interacts with the T-antigen epimer Gal-1,3-GlcNAc, especially if a sulfate group on the reducing GlcNAc ring is present (glycan n. 444 and 510).
A more detailed analysis of N-Epa1p mutant specificities was performed by the interpretation of glycan array screening results obtained with 20 g/ml protein samples ( Figure 3A and Figure S3 ). Concerning the glycan series containing a Gal-1,3 moiety ( Figure S4 ), one difference arises for the Gal-1,3-GalNAcstructure containing the reducing GalNAc anomer (glycan n. 139-141). In this case, all mutants show a reduced binding specificity and preference for the  anomer in contrast to the relative promiscuity of the wild-type adhesin. From the 20 g/ml data analysis, the increased affinity of the Y228A mutant for Gal-1,3-GlcNAc is evident, and, even more striking is the preference for the two Gal-1,3-Gal -containing structures, which are the best ligands for this N-Epa1 variant. A general decrease in specificity is observed for some linear Gal-1,4 series ( Figure S4) , with an exception for Y228A, relatively to lactose and dimers of lactosamine linked by a 1,6-glycosidic linkage. Additionally, the same variant of N-Epa1p cannot distinguish between the T-antigen and
Gal-1,4-GlcNAc.
Molecular docking of sulfated disaccharides to N-Epa1 variant structures
An attempt to explain the structural basis of the increased specificity of N-Epa1p mutants for sulfated disaccharides was made by performing computational docking simulations with the N-Epa1p structures (wild type, E227A and Y228A) and models of the sulfated disaccharides [6-SO 3 K117 ( Figure 4A ) or R226. In the case of the E227A mutant, these two conformations are not computed as energetically equivalent. The proximity with R226 of the sulphate-GlcNAc is predicted as highly probable ( Figure 4B ), while significantly higher energies are attributed to all other solutions.
Similarly Figure 4C ) and the mutant ( Figure 4D ) are identical, with similar predicted binding energies.
However, the carbohydrate is slightly tilted towards the R226 side chain in the wild type binding pocket, likely generated by the repulsion between the tyrosine aromatic ring and the acetyl group on the GlcNAc reducing end.
Discussion
We engineered the binding site of the N-terminal carbohydrate-binding domain of Epa1p in order to improve its affinity towards fibronectin. Moreover, we investigated how the mutation of some key amino acids in the binding pocket can affect the specificity of carbohydrate recognition by the epithelial adhesin. Previously, the glycan specificity of a galectin from the mushroom Agrocybe cylindracea (ACG) that was able to bind N-acetyl lactosamine and the T-antigen, has been modified by saturation mutagenesis, targeting amino acids involved in glycan recognition. In a first case, the mutation of E86 with an aspartate removed the affinity for Gal-1,4-GlcNAc and Gal-1,3-GalNAc moieties, while the affinity for sialyl residues with an -2,3-glycosidic linkage was preserved (Imamura et al., 2011) . Also, the N46A mutant of the same lectin was characterized by increased affinity for the GalNAc-1,3-Galdisaccharide and, consequently, for the blood group A and Forssman antigens (Hu et al., 2013) , while binding to other -galactosides was significantly decreased.
We used saturation mutagenesis to produce libraries of N-Epa1p variants, mutated in positions E227 and Y228. These amino acids are part of the CBL2 variable loop, which is involved in and Y228 with less sterically hindering amino acids favors the accommodation of galactosides with different glycosidic linkages, thus broadening glycan specificity. Moreover, it was suggested that aromatic residues in position 228 are effective in packing interactions with the reducing ends of Gal-1,3-Glc(NAc) or Gal-1,3-Gal(NAc) moieties.
Based on these considerations, we hypothesized that the higher affinity of the Y228W mutant can be explained by an enhanced O-glycan binding, especially of -1,3-linked moieties, possibly generated by the more extended aromatic -electron delocalization of the tryptophan side chain. On the other hand, the higher affinity for fibronectin shown by the E227A mutant is less clear, but the presence of 6-OH-sulfated moieties on fibronectin glycans may be the responsible factor. Covalent modification of fibronectin with sulfated proteoglycans, such as chondroitin sulfate or dermatan sulfate, has been described (Burtonwurster and Lust, 1993) . Therefore, the N-Epa1p mutant could possibly interact, more efficiently than the wild-type adhesin, with the terminal sulfated residues of proteoglycan chains linked to fibronectin.
Overall, the main finding of our work is the dramatically increased binding, relative to the Tantigen, to sulfated lactose and lactosamine disaccharides of the E227A and E227G mutants. This is most likely caused by the absence of the glutamate side chain, which is supposed to eliminate the electrostatic repulsion between the negatively charged carboxylic group and the sulfate groups positioned on the ligands. Also, the E227G mutant specificity for a sulfate group on the reducing end is possibly explained with the compensation of the missing E227 contribution in the disaccharide binding with an interaction between the SO 3 -group and the near and positively charged R226. The latter interaction doesn't seem to stabilize the carbohydrate binding by the E227A mutant, whose alanine may still hinder any interaction between the arginine side chain group and the sulfate function.
The Y228A mutant also showed enhanced specificity for sulfated disaccharides and, in particular, a sulfate group on the reducing residue was found to be critical for binding of -1,3-linked molecules. However, this is probably the result of a better accommodation of the sulfated carbohydrates in the binding pocket due to the presence of a less sterically hindering alanine.
Molecular docking for this mutant suggested indeed an interaction between 6-SO 3 -groups on reducing Sulfated O-glycans that contain a 6-sulfo galactose moiety, can be found throughout the body and are sometimes associated with tumors. For instance, they have been found on the mucin MUC1, which are produced by breast cancer cells (Seko et al., 2012) . More generally, sulfomucins are found in different tissues of the gastrointestinal and urogenital tracts of the human body (Nieuw Amerongen et al., 1998) . Sulfated lactosamine also represents the repetition unit of the glycosaminoglycan keratan sulfate (Reitsma et al., 2007; Fundemburgh, 2000) , which is associated to corneal cells and articular cartilage glycosylation. Keratan sulfate is also synthesized in the brain, and its production is increased in some forms of brain tumors, included astroctyoma and glioblastoma Hayatsu et al., 2008) .
At present, there is however a lack of molecular probes able to specifically recognize glycans containing the 6S-Gal moiety. The TJA-I lectin, from the plant Tricosanthes japonica, can bind sulfated galactose (Yamashita et al., 1992) , but its additional interactions with sialo-and asialo-Gal moieties make this protein not suitable for the specific identification of 6S-Gal on biological substrates.
Directed evolution of a ricin-type lectin (EW29Ch), on the other hand, has been previously carried out for the generation of a 6-sulfogalactose-specific molecule by a combination of random and sitedirected mutagenesis, and a glycoconjugate array detection system . The resulting 6S-Gal-specific mutant, used in combination with the EW29Ch template, led to the specific in vitro identification of the sulfated glycoepitope overexpressed onto 6-O-Gal-sulfotransferase-transfected CHO cells.
Lectins represent a precious tool for glycan profiling and diagnostics. Applications include the generation of affinity chromatography stationary phases for the purification of human antibodies and other plasma glycoproteins (Kabir 1998) , the structural characterisation of sugars linked to glycoproteins (Kaji et al., 2003) , and the detection of subtle differences in protein glycosylation due to various diseases (Satish and Surolia, 2001) . Moreover, the generation of microarray devices can be of outstanding importance not only for the high-throughput analysis of the glycosylation pattern on single glycoproteins, but also to investigate the carbohydrate expression on bacteria or mammalian cells for diagnostic purposes (Tateno et al., 2007; Gemeiner et al., 2009; Smith and Cummings, 2013) . Tailoring of Epa adhesins, and other yeast adhesin for the recognition of target glycoproteins or even specific glycan molecules could thus represent a novel source of proteins with lectin activity to be used as probes in different applications.
In conclusion, the engineering of the CBL2 loop in the Epa1p N-terminal domain led to the generation of two single-point mutants endowed with higher binding affinity for fibronectin. More strikingly, some of the mutations produced an important change in specificity, dramatically restricting the range of possible structures recognized by the adhesin lectin domain. We propose that this method can be applied to increase the recognition of other glycoproteins by any Epa adhesin from C.
glabrata, as well as by other adhesins with a lectin-like activity, such as the Flo adhesins from S.
cerevisiae (Veelders et al., 2010; Ielasi et al., 2013) . Furthermore, other strategies could be applied to modulate protein specificity towards glycan molecules, for example the combination of the characterized single-point mutations into double mutants, random mutagenesis or the modification of other key amino acids in the binding pocket, such as R226 or D229.
Materials and methods
Preparation of DNA libraries
The gene encoding the N-terminal lectin domain of Epa1 (N-Epa1p), inserted into the pET-21b(+)
vector (Ielasi et al., 2012) , was randomized at positions E227 and Y228 by site-saturation mutagenesis. Libraries of mutants were generated using the forward primers Fw_E227NNS (5'-14 TAGGTTATTTTATAATAACAGANNSTATGATGGTGCACTCAG-3'), Fw_Y228NNS (5'-TAGGTTATTTTATAATAACAGAGAANNSGATGGTGCACTCAGTTTTAC-3'), the reverse primer Rv_MP (5'-TACGATACGGGAGGGCTTAC-3') and the Phusion High Fidelity DNA Polymerase (New England Biolabs) in a modified megaprimer-whole plasmid protocol (Sanchis et al., 2008) . A first PCR amplification of a 1700 bp megaprimer was run, using final concentrations of 0.2 ng/µl for the plasmid template, 0.25 M for the primers and 0.2 mM for the dNTP mixture (30 s at 98°C, followed by 30 cycles of 10 s at 98°C, 20 s at 50°C and 40 s at 72°C, with a final 5 min at 72°C). The amplified DNA megaprimers mixtures were treated with DpnI to remove the plasmid template, and then used for a whole plasmid PCR. This required 0.2 ng/µl of template, 4 ng/µl of megaprimers and 0.2 mM of dNTP mixture (30 s at 98°C, followed by 25 cycles of 10 s at 98°C and 4 min at 72°C, with a final 5 min at 72°C). The purification of the plasmid libraries was performed with a QIAprep Miniprep kit (Qiagen).
The variability of mutated codons was checked by DNA sequencing.
Enzyme linked lectin assay (ELLA) screens
DNA libraries were used to transform electrocompetent Escherichia coli Origami 2 (DE3) cells. The transformed cells were plated on agar solid medium supplemented with 100 g/ml ampicillin and grown overnight at 37°C. Colonies were picked from cultures with the QPix II system (Genetix) and used to inoculate 96-well plates filled with 175 µl LB and 100 g/ml ampicillin. For each library, two plates were prepared in order to have sufficient codon variability. These were shaken overnight at 37°C, and then supplemented with glycerol to a final concentration of 20% v/v in order to allow storage at -20°C.
For screening experiments, master plates were used to inoculate other LB-ampicillin 96-well plates. After overnight growth at 37°C, cultures were induced for protein expression with isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 50 M and shaken for 3 days at 12°C.
Cells were harvested at 4500 rpm for 30 min, and frozen overnight at -80°C. For cell lysis, pellets were resuspended in a buffer containing 1 mg/ml lysozyme, 0.05 % w/v bovine serum albumin (BSA), 50 mM Tris-HCl, 50 M NaCl, 10 mM CaCl 2 , 4 mM MgCl 2 and 0.1 mM phenylmetylsulfonyl fluoride (PMSF) as protease inhibitor, and incubated for 1 h at room temperature. Bacterial lysates were incubated for 1 h at room temperature in MaxiSorp plates (Nunc), previously coated with fibronectin (BD Biosciences, 10 g/ml protein in 100 mM NaHCO 3 buffer pH 9.5, overnight incubation at 4°C, followed by blocking with 2% w/v BSA in PBS). Afterwards, wells were incubated for 1 h with anti-His by guest on July 21, 2014
http://glycob.oxfordjournals.org/ Downloaded from tag mouse primary antibody (AbD Serotec) in PBS -BSA 0.2% w/v, followed by 1 h with anti-mousealkaline phosphatase (AP) secondary antibody (Sigma) in the same buffer, and the AP substrate 2,4-dinitrophenyl phosphate (DNPP) in 100 mM Tris-HCl pH 9.5, 5 mM MgCl 2 , 100 mM NaCl. Between the incubation steps, the wells were washed 4 times with 0.05% Tween-20 in PBS. After the addition of the AP substrate, the increase in absorbance at 405 nm was followed during 60 min, with one measurement every minute (Biochrom Anthos Zenyth 200rt microplate reader).
To evaluate differences in binding among N-Epa1p mutants to fibronectin, kinetic plots were constructed for all wells. The wells were ranked according to the slope values (which were assumed as proportional to the amount of bound mutants) and these were compared to the average slope obtained from a plate containing only wild type N-Epa1p. Mutants with a slope that exceeded the average value (Avg) for twice the standard deviation (SD), were considered as hits and identified by DNA sequencing.
Protein purification
Purification of N-Epa1p for binding assays was performed following the procedure already indicated elsewhere (Ielasi et al., 2012) .
Surface Plasmon Resonance (SPR)
The binding measurements were performed using the BIAcore 3000 system (GE Healthcare). The increasing concentrations of N-Epa1p variants were injected over CM5 chips, on which fibronectin was immobilized via an amine coupling method. A reference cell was coated with an equal amount of BSA. The running buffer used was 10 mM CaCl 2 , 150 mM NaCl, 0.005% v/v Tween 20 and 10 mM Hepes pH 7.4 (HBS). The injection was performed at 25°C using a flow rate of 20 μl/min for 2 min.
The dissociation was then monitored for 7 min. After the dissociation phase, the chip surface was regenerated with 5 mM NaOH. Binding was determined by measuring the increase in resonance units after subtraction of the background response obtained from the reference flow cell and the sample containing only the buffer. The dissociation constants at the equilibrium state (K D ) were determined from binding experiments with a single set of concentrations and estimated using the following steady-state affinity model with a 1:1 ligand-analyte ratio: R eq = R max (K A C A )/(K A C A +1) where R eq is the response at the equilibrium state, K A is the association constant at the equilibrium state, C A is the analyte concentration and R max is the maximum binding capacity for the particular experimental condition. The results were analysed with the BIAevaluation software version 4.1 (GE Healthcare) and with Prism 6 (GraphPad) software.
Glycan array analysis
N-Epa1 wild type and mutants were subjected to glycan array screening for binding to glycans printed on a glass slide microarray (version 5.1) developed by the Consortium for Functional Glycomics (Blixt et al., 2004) Screenings were performed at concentrations of 20 μg/ml and 200 μg/ml. The detection of the proteins bound to the arrays was achieved by using the same anti-His tag primary and antimouse-AP secondary antibodies as employed for the ELLA screenings. The average relative fluorescence units were obtained for four replicates for each glycan. Error bars are based on the standard error of the mean (SEM) for these replicates.
Molecular docking simulation
Generation of the models for the E227A and Y228A mutants and the (Ielasi et al., 2012) and mutant structures was carried out using the molecular modeling program YASARA and the YASARA/WHATIF twinset (Vriend, 1990; Krieger et al., 2002) . N-Epa1 structures were prepared for docking by adjusting the pH to 7 ensure the correct charge of the side chains and by optimizing the hydrogen network (Hooft et al., 1996) using the YASARA/WHATIF twinset. A cubic search grid of 20 Å was defined to cover the N-Epa1binding site.
The flexibility of ligands was accounted for by allowing the rotation around flexible torsion angles.
Docking was subsequently performed with VINA (Trott and Olson, 2010) using the AMBER03 force field for charge assignment (Duan et al., 2003) with default parameters, and all residues in the pocket were kept fixed. The setup for docking was done with YASARA Structure (Krieger et al., 2002) and the top hits out of hundred runs were selected for further analysis. by guest on July 21, 2014
